| 000 | 01435 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514015316.0 | ||
| 264 | 0 | _c20020520 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0927-3042 | ||
| 024 | 7 |
_a10.1007/978-1-4615-1463-3_14 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAudeh, M W | |
| 245 | 0 | 0 |
_aMDS and secondary AML: an evolutionary perspective. _h[electronic resource] |
| 260 |
_bCancer treatment and research _c2001 |
||
| 300 |
_a267-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBiotransformation _xgenetics |
| 650 | 0 | 4 |
_aBone Marrow Cells _xpathology |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 |
_aClone Cells _xpathology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfections _xcomplications |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xetiology |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdrug therapy |
| 650 | 0 | 4 |
_aNeoplastic Stem Cells _xpathology |
| 650 | 0 | 4 |
_aPreleukemia _xdrug therapy |
| 650 | 0 | 4 | _aSelection, Genetic |
| 650 | 0 | 4 |
_aXenobiotics _xadverse effects |
| 773 | 0 |
_tCancer treatment and research _gvol. 108 _gp. 267-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-1-4615-1463-3_14 _zAvailable from publisher's website |
| 999 |
_c11617834 _d11617834 |
||